tb mdr tb control updates myanmar n.
Download
Skip this Video
Loading SlideShow in 5 Seconds..
TB, MDR – TB control updates, Myanmar PowerPoint Presentation
Download Presentation
TB, MDR – TB control updates, Myanmar

Loading in 2 Seconds...

play fullscreen
1 / 35

TB, MDR – TB control updates, Myanmar - PowerPoint PPT Presentation


  • 249 Views
  • Uploaded on

TB, MDR – TB control updates, Myanmar. CAP-TB Strategic Planning Meeting, Bangkok, Thailand, 1-2 August, 2013. TB burden . TB is a major public health problem One of the world’s 22 high TB burden countries, 27 high MDR-TB burden countries and 41 high TB/HIV burden countries.

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about 'TB, MDR – TB control updates, Myanmar' - ely


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
tb mdr tb control updates myanmar

TB, MDR – TB control updates, Myanmar

CAP-TB Strategic Planning Meeting,

Bangkok, Thailand, 1-2 August, 2013

tb burden
TB burden
  • TB is a major public health problem
  • One of the world’s 22 high TB burdencountries, 27 high MDR-TB burden countries and 41 high TB/HIV burden countries

Estimates of the TB burden in Myanmar, 2011 (based on 2009-2010 prevalence survey), source: WHO TB Control Report 2012

slide3

TB epidemiology, Myanmar (2011)

Mortality

Prevalence

Incidence

slide4

HIV Sentinel Surveillance in Myanmar

2005 – 5 tsps

2012 – 25 tsps

goal objectives targets
Goal, Objectives & targets

Goal

  • To reduce morbidity, mortality and transmission of TB until it is no longer a public health problem and to prevent the development of drug resistant TB.
  • Specific Objectivesare set towards achieving the Millennium Development Goals (MDGs) for 2015.

To reach and thereafter sustain the targets

      • achieving at least 70% case detection and successfully treat at least 85% of detected TB cases under DOTS
  • (MDGs: Goal 6, Target 6.c, Indicator 6.10)

To reach the interim targets of halving TB deaths and prevalence by 2015 from the 1990 situation.

  • (MDGs: Goal 6, Target 6.c, Indicator 6.9)
slide10

MDGs for TB Control

 6.9 Global Tuberculosis Control 2010, WHO, Geneva

# 6.10 National Tuberculosis Programme, Department of Health, Ministry of Health, Annual Reports (2000-2009)

estimates of mdr tb burden 2012
WHO estimates that there were 5,500 MDR-TB cases among notified pulmonary TB cases in 2011

Among the total annual TB cases 9,000 are estimated to have MDR-TB

A total of 6 XDR-TB cases have been confirmed

Estimates of MDR-TB burden (2012)
mdr tb suspects definition and diagnostic algorithms
MDR-TB suspects definition and diagnostic algorithms
  • Patient to be tested for drug sensitivity
  • Retreatment cases including Category II failure, Category I failure, relapse and return after default and other cases
  • Close contacts of MDR-TB patients who develop active TB
  • All TB patients living with HIV/AIDS
  • Three diagnostic algorithms developed
  • based on Xpert MTB/RIF:
  • Diagnosis of TB in HIV-negative patients with no significant risk for MDR-TB
  • Diagnosis of TB/MDR-TB in HIV-positive TB patients
  • Diagnosis of MDR-TB in patients with risk factors for resistance
treatment regimens
Treatment Regimens

Standardized treatment regimens

  • 6 Am + Lfx + Eto + Cs + Z
  • 18 Lfx + Eto + Cs + Z

OR

6 Am + Lfx + Eto + Cs + PAS + Z

18 Lfx + Eto + Cs + PAS +Z

key activities to date to combat drug resistant tb
DOTS-Plus pilot project started in July 2009

The Global Fund supported MDR-TB management started in December 2011

SOP of pilot phase was reviewed and revised in 2012.

Model of MDR-TB care –community-based

Patients enrolment category – expanded beyond Cat II failure

Treatment regimen revised – PAS to be included only for Cat II failure MDR-TB patients

MDR-TB township expansion started in 2012 according to scale up plan (2011-2015)

MDR townships expanded from 22 to 38/ 330 townships in 6 States/Regions

(Yangon 18, Mandalay 11, Sagaing 3, Magway 2, Mon 2, Shan 2)

Key activities to date to combat drug resistant TB
number of mdr enrolled on treatment 2009 2013 2nd quarter
Number of MDR enrolled on treatment 2009-2013 (2nd quarter)

MDR TB Patients

Pilot YGN: 266

MDY: 43

GF YGN: 631

MDY: 107

Other State and Region: 37

Total = 1,084

End DOTS-Plus pilot project

cohort report treatment outcome july 2009 june 2011
Cohort report, Treatment Outcome(July 2009 - June 2011)

Total cohort cases (July 2009 – June 2011) ---- 309 cases

Died before treatment ---- 6 cases

Still on treatment ---- 16 (MDY- 5 cases & YGN- 11 cases)

key activities to improve management of tb in hospitals
MDR-TB management in hospitals (free of charge to the patient):

Vehicle is available for referring and transfer of patients to various Specialist Hospitals if needed

Nutritional support for MDR-TB patients hospitalized

Side effect management

Laboratory investigations

Infection control measures have been upgraded

TB Control in Hospitals:

23 hospitals are under Public-Public Mix DOTS, however, weak commitment to treat MDR.

Key activities to improve management of TB in hospitals
family health international 360
Family Health International 360
  • FHI 360 work in close collaboration with the National Tuberculosis Programme and implement activities in Mandalay and Yangon initially through 4 local partners:

1. Myanmar Medical Association (MMA)

2. Pyi Gyi Khin (PGK)

3. Myanmar Health Assistant Association (MHAA)

4. Myanmar Business Coalition on AID (MBCA)

tb hiv collaborative activities in 2011 to 2012 vcct
TB/HIV collaborative activities in 2011 to 2012 (VCCT)

51%

65%

48%

61%

  • Calculation based on 15 TB/HIV sites in 2011 and 18 TB/HIV sites in 2012
key activities to improve management of tb by private providers
Private providers engaged at national scale:

Population Services International (PSI): 190 tsps, 855 GPs

Myanmar Medical Association (MMA): 116 tsps, 1443 GPs

Contributing to about 16% of TB notifications

ISTC adopted & disseminated since 2009

Key activities to improve management of TB by private providers
major challenges in combating drug resistant tb
Major Challenges in combating drug resistant TB
  • Strengthen human resources (number and skills), willingness of physicians
  • Referral network for utilization of Xpert
  • Timely arrival of second-line anti-TB drugs
  • Ensure ancillary drugs and support for infection control
  • Geographical expansion
  • Expand MDR-TB follow-up sites (decentralization)
  • Provide more incentive for Basic Health Staff
  • Ensure/sustain nutritional support for MDR-TB patients
  • Infection control measure for health care settings
expansion plan with committed resources
Expansion plan (with committed resources)
  • Patients to be treated also in 2014
  • Reference labs and Xpert MTB/RIF more ambitious that MDR-TB scale-up plan
  • MDR-TB patient enrollment less ambitious than MDR-TB scale-up plan
planned activities
Case detection and diagnosis of MDR-TB by Xpert MTB/RIF, Liquid Culture and LPA for all retreatment cases

Second-line anti-TB drug procurement:

2013: 508 (Global Fund and UNITAID)

2014: 1084 (Global Fund)

2015: 800 (Global Fund)

2016: 1000 (Global Fund)

MDR-TB support package for providers and patients

Procurement of infection control materials

Expansion of an additional three culture & DST laboratories

Timely procurement of lab. consumables for culture and DST

Planned activities
planned activities1
Publication and dissemination of new guidelines

Geographical expansion 15 townships per year to 38 townships in 2014 (major training activities planned)

Xpert MTB/RIF will be expanded in 2013-2014

12 machines up and running

4 machines from UNITAID (2013)

6 machines from PEPFAR

16 from GF (8 in 2013 and 8 in 2014)

Increase of DOT provider allowance and patient support (nutrition and transportation)

Planned activities
future plan fhi
Future Plan (FHI)

Expansion of Activities in Yangon

PGK : 2 new townships (ShwePyiThar and NorthOkkalarpa Township)

MHAA: 2 new townships (Insein and HlaingTharYar)

Activities will be the same as current townships

Expansion of Activities in Mandalay (MHAA)

To expand 3 more townships and activities will be the

same.

Expansion of Activities in Monywa (MBCA)

To support package of services to MDR-TB patients by

conducting home base care activities

progress and achievements 2011 2013 in implementing the stop tb strategy
Progress and achievements (2011-2013) in implementing the Stop TB Strategy
  • Nationwide DOTS
  • EQA system on sputum smear microscopy for 425 laboratories, introduced iLED fluorescence microscope to district.
  • TB-HIV sentinel surveillance in 25 sites, TB/HIV collaborative activities in 28 townships.
  • MDR-TB pilot successful and now expanding to programmatic MDR-TB management.
  • Successful PPM at nationwide scale, 20 partners involving in TB control.
  • Community based TB control activities with NGOs started in 154 townships (international NGOs in 23 townships).
  • Operational Research are conducting in collaboration with Dept. of Medical Research.
slide33

Funding gap (2011-2015) (USD in million)

GF (NFM) – 82.3 Million USD, 3MDG - ~ 17 Million USD (2013-2016)

slide34

Issues and challenges

  • Sustainability of current achievement is limited due to following issues:
  • Limitation in human resource development
  • Limitation in capacity building
  • Improving case finding and treatment outcomes in selected townships (border and remote) with high treatment interruption rates and low community involvement in TB control
  • Limited access to HIV care for TB/HIV co-infected patients
  • Limited resources for MDR-TB management (Availability of diagnostic facilities and SLD, infection control measures)
  • Need technical assistance for new tools
  • Paper based R&R
new technology

X pert

New technology

LPA

FM

Thank you

MGIT